TaBriX was proud to be represented at BIO-Europe Spring 2026, where founder Dr Lydia Tabernero spoke at one of Europe’s leading life sciences partnering events.
Held in Lisbon from 23–25 March 2026, BIO-Europe Spring brings together more than 3,700 leaders, innovators, investors and business development professionals from across the global biotechnology and pharmaceutical sectors. The event is recognised as Europe’s largest springtime biotech partnering conference, creating opportunities for collaboration, licensing discussions and strategic partnerships across the life sciences ecosystem.
Speaking at such a globally recognised event reflects TaBriX’s growing profile within the life sciences sector and its dedication to engaging with key stakeholders shaping the future of biotech innovation.
